1. Home
  2. STT vs KVUE Comparison

STT vs KVUE Comparison

Compare STT & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo State Street Corporation

STT

State Street Corporation

HOLD

Current Price

$123.75

Market Cap

32.3B

Sector

Finance

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.88

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STT
KVUE
Founded
1792
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Specialty Chemicals
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
33.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
STT
KVUE
Price
$123.75
$18.88
Analyst Decision
Buy
Buy
Analyst Count
13
12
Target Price
$135.92
$19.58
AVG Volume (30 Days)
2.2M
61.3M
Earning Date
01-16-2026
02-17-2026
Dividend Yield
2.55%
4.48%
EPS Growth
14.49
35.31
EPS
9.40
0.75
Revenue
$13,885,000,000.00
$15,006,000,000.00
Revenue This Year
$6.91
N/A
Revenue Next Year
$4.30
$2.72
P/E Ratio
$14.00
$24.80
Revenue Growth
7.43
N/A
52 Week Low
$72.81
$14.02
52 Week High
$137.05
$25.17

Technical Indicators

Market Signals
Indicator
STT
KVUE
Relative Strength Index (RSI) 39.85 76.51
Support Level $129.13 $17.96
Resistance Level $135.36 $18.55
Average True Range (ATR) 3.73 0.38
MACD -0.41 0.11
Stochastic Oscillator 4.27 94.83

Price Performance

Historical Comparison
STT
KVUE

About STT State Street Corporation

State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: